Biotherapeutics Market Analysis and Reports | USA Conference Series

Market Analysis - Biotherapeutics 2017

Biotherapeutics Cell Line Development Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2022

Biotherapeutics or biologic or biotech drugs are derived from living organisms and used to treat fatal diseases like cancer, rheumatoid arthritis, sclerosis and others. The global cancer therapeutic market is segmented into four major regions such as Europe, North America, Asia- Pacific and RoW. The demand for biotherapeutics has witnessed a significant rise to the increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cancer, and multiple sclerosis. This growth in the demand for Biotherapeutics, together with the imminent launch of several biopharmaceutical drugs, has created a substantial demand for cell line development. With the increasing number of recombinant protein therapeutics gaining approval by the U.S. Food and Drug Administration (FDA) annually, there is an increase in the demand of cell lines for production of these biotherapeutics. From 2006 to 2011 an average of 15 novel recombinant protein therapeutics and the ClonePix accounted for the largest market share of 37.4%in 2014, 11 novel recombinant protein therapeutics have been approved by US FDA. About forty-seven monoclonal antibody products have been approved in the U.S., Europe and other global markets, of which over 60% were produced in mammalian cell culture.

However, unmet medical needs in emerging economies of Asia Pacific, Latin America, and Africa, is expected to provide lucrative opportunities for market players over the next few years. The global market for is estimated to with the opportunity in Biotherapeutics cell line development will rise from US$56 mn in 2014 to nearly US$100 mn by 2022, rising at a CAGR of 7.50% between 2015 and 2022. North America has acquired the leading position in the worldwide market for Biotherapeutics cell line development. In 2014, the opportunity in this region stood at US$23.5 mn, which is likely to increase to US$41 mn by the end of 2022.

Europe, which emerged second in this market in 2014, is expected to report steady growth in the near future. The future of cell line development in biotherapeutics, however, lies in Asia Pacific, which stood at third position in 2014. The potential that this region holds can be understood by the fact that Asia Pacific is expected to register the fastest CAGR of 9.40% during the forecast period. The unmet medical needs and the increasing investments by major pharma companies is projected to amplify the development of Biotherapeutics cell line in this region. the increasing number of initiatives taken by the government of various countries by funding the life science research and development is expected to propel this market in coming years.

Biotherapeutics 2017 Organizing Committee takes immense pleasure to invite you all to be a part of this meeting which will focus on current trends and emerging issues in Biotherapeutics and Bioanalytical Techniques. Conference Series LLC Conferences desideratum is to render an intriguing forum and vibrant opportunity for researchers to share their original research results and practical experiences, at the same time absorb knowledge from works being done around the nooks of world. Apart from researchers, professors, biopharmaceutical industry practitioners, private and public investors, and students are also most welcome to get themselves inbuilt to the rays of novel happenings on Biotherapeutics and Bioanalytical Techniques around the globe. The whole concept of this advanced technology is to agenized from past, analyze the present and implement for the future the latest innovative evolving theories and technologies to surpass the hurdles and make modish frontiers. This will be the best event for academicians, researchers and interested parties to discuss proposals and most sound issues related to Biotherapeutics and Bioanalytical Techniques like Chromatographic Techniques, Advancements in Biotherapeutics, MicroRNAs (miRNAs) Biotherapeutics etc.

Major Manufacturers analysed in Biotherapeutics Market are:

  • Beckman Coulter, Inc.
  • Boehringer Ingelheim Pharma GmbH & Co KG.
  • Catalent, Inc.
  • CMC Biologics
  • Lonza Group Ltd.
  • Partec
  • ProBioGen AG
  • SAFC
  • Selexis SA
  • Thermo Fisher Scientific, Inc.